Regulatory Affairs Research Articles

Regulatory affairs research articles

Pharmaceutical Regulatory Affairs Open Access journal is a comparatively new profession that developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics, and complementary medicines. The companies responsible for the discovery, testing, manufacture, and marketing of these products also want to ensure that they supply products that are safe and make a worthwhile contribution to public health and welfare. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as an editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 3000+ International Scientific Conferences and events yearly all over the world with the support of 1000+ Scientific associations worldwide. Pharmaceutical Regulatory Affairs: Open Access journals play a key role in knowledge societies and this knowledge is rising by leaps and bounds within no time. Scientists and academicians require a broad understanding of the latest updates in the respective discipline for their professional and learning endeavors. OMICS International with its open access journals represents the research findings and advancements in various scientific and medical disciplines. Pharmaceutical Regulatory affairs is a journal dedicated to producing analysis, insight, and data relating to questions of importance in understanding the Regulatory affairs.

High Impact List of Articles

Conference Proceedings

Assessment for the use of nutritional support in Turkey
Beril Koparal, Aysenur Koc, Kubra Erdogan, Nazan Arslan, Sidika Buyukhelvacigil Ozturk and Ali Aysakar
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Assessment for the use of nutritional support in Turkey
Beril Koparal, Aysenur Koc, Kubra Erdogan, Nazan Arslan, Sidika Buyukhelvacigil Ozturk and Ali Aysakar
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Transcriptional regulation of leucine-rich repeats and WD repeat domain containing 1 (LRWD1) by microRNA under reactive oxygen species
Teng Yen-Ni, Chia-Hui Su, Ming-Syuan Wu, Jie-Yun Tseng and Hsing-Yi Chen
Posters & Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Transcriptional regulation of leucine-rich repeats and WD repeat domain containing 1 (LRWD1) by microRNA under reactive oxygen species
Teng Yen-Ni, Chia-Hui Su, Ming-Syuan Wu, Jie-Yun Tseng and Hsing-Yi Chen
Posters & Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Synthesis of analogs of natural tubulin polymerization inhibitors using Parsley and Dill seed extracts
Victor V Semenov and M N Semenova
Scientific Tracks Abstracts: Journal of Pharmacognosy & Natural Products
Synthesis of analogs of natural tubulin polymerization inhibitors using Parsley and Dill seed extracts
Victor V Semenov and M N Semenova
Scientific Tracks Abstracts: Journal of Pharmacognosy & Natural Products
Demonstration of multivariate data analysis for the development of Boswellia serratta plant extracts containing nanoemulsion
Mukesh Gohel, Asha Patel, Tejal Soni and Lal Hingirani
Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Demonstration of multivariate data analysis for the development of Boswellia serratta plant extracts containing nanoemulsion
Mukesh Gohel, Asha Patel, Tejal Soni and Lal Hingirani
Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Biosimilars: Less than a decade and a new paradigm already?
Stephanie C. Finnegan
Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Biosimilars: Less than a decade and a new paradigm already?
Stephanie C. Finnegan
Accepted Abstracts: Journal of Bioanalysis & Biomedicine

Pharmaceutical Regulatory Affairs: Open Access